What is Caliber Imaging & Diagnostics, Inc. (LCDX) stock price today?

Caliber Imaging & Diagnostics, Inc. (LCDX) is currently trading at $0.00.

What is LCDX P/E ratio?

Caliber Imaging & Diagnostics, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is LCDX return on equity (ROE)?

Caliber Imaging & Diagnostics, Inc.'s return on equity (ROE) is 41.67%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Caliber Imaging & Diagnostics, Inc.'s market cap?

Caliber Imaging & Diagnostics, Inc. has a market capitalization of $7657.

OTC · Medical - Devices

Caliber Imaging & Diagnostics, Inc. (LCDX) Stock

$0.00 OTC: LCDX Healthcare

Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution.

Valuation

Metric	Value
Price	$0.00
Market Cap	$7657
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.05
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	41.67%
ROA	-174.77%
ROCE	96.99%
Gross Margin	15.47%
Operating Margin	-184.75%
Net Margin	-198.99%
Debt/Equity	-1.00
Current Ratio	0.22

Annual Financials (USD)

Metric	2009	2010	2011	2012	2013
Revenue	$2.0M	$3.0M	$4.0M	$2.0M	$3.0M
Operating Profit	$-4.0M	$-4.0M	$-7.0M	$-8.0M	$-5.0M
Net Profit	$-4.0M	$-4.0M	$-9.0M	$-10.0M	$-5.0M
EPS	$-1.87	$-1.99	$-7.37	$-1.23	$-0.65
Op Margin	-153.9%	-135.4%	-183.6%	-342.9%	-145.2%

Balance Sheet (USD)

Metric	2009	2010	2011	2012	2013
Total Assets	$1.0M	$2.0M	$6.0M	$3.0M	$2.0M
Total Liabilities	$10.0M	$10.0M	$7.0M	$10.0M	$15.0M
Cash	$0	$1.0M	$5.0M	$1.0M	$1.0M
Borrowings	$4.0M	$6.0M	$4.0M	$7.0M	$12.0M

Latest News

Markets Don’t Buy the US Ceasefire Against Iran Will Last decrypt · Jul 28, 2026 Two dead in shopping mall hit by Japan quake AFP · Jul 28, 2026 3 Financials Stocks Worth Investigating StockStory · Jul 28, 2026 LibertyStream Announces Closing of Non-Brokered Private Placement of Units Business Wire · Jul 28, 2026 REPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug Stocktwits · Jul 28, 2026

Cash Flow (USD)

Metric	2009	2010	2011	2012	2013
Operating Cash Flow	$-1.0M	$-4.0M	$-5.0M	$-8.0M	$-5.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$1.0M	$4.0M	$-4.0M	$0
Free Cash Flow	$-1.0M	$-4.0M	$-5.0M	$-8.0M	$-5.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-2.35
FCF Yield	-63534.44%
Quick Ratio	0.21
Interest Coverage	-6.37
Return 1Y	800.00%
Return 3Y	125.00%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.15%

Institutions Float Held0.15%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BBALNew York Health Care, Inc.	$0.00	—	0.00	$3354	0.00%
FPMIFluoroPharma Medical, Inc.	$0.00	—	0.00	$6852	0.00%
LPTILongport, Inc.	$0.00	—	—	$2308	0.00%
NMRDNemaura Medical Inc.	$0.00	—	0.00	$4035	0.00%
NMXSNet Medical Xpress Solutions, Inc.	$0.00	—	-0.01	$26367	0.00%

About Caliber Imaging & Diagnostics, Inc.

Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.

Caliber Imaging & Diagnostics, Inc. (LCDX) stock trades at $0.00 with a market capitalization of $7657. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.05, and currently trades 100.0% below its 52-week high.

On profitability, Caliber Imaging & Diagnostics, Inc. generates a return on equity (ROE) of 41.67% — well above the market average, a sign of a high-quality business, return on capital employed of 96.99%, an operating margin of -184.75%, a net profit margin of -198.99%.

Official website: www.caliberid.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides